1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Neurology Clinical Trials Market
2.3. Global Neurology Clinical Trials Market, By Phase, 2025 (US$ Million)
2.4. Global Neurology Clinical Trials Market, By Study Design, 2025 (US$ Million)
2.5. Global Neurology Clinical Trials Market, By Indication, 2025 (US$ Million)
2.6. Global Neurology Clinical Trials Market, By Geography, 2025 (US$ Million)
2.7. Attractive Investment Proposition by Geography, 2025
3. Neurology Clinical Trials Market: Competitive Analysis
3.1. Market Positioning of Key Neurology Clinical Trials Market Vendors
3.2. Strategies Adopted by Neurology Clinical Trials Market Vendors
4. Neurology Clinical Trials Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Neurology Clinical Trials Market Value, 2024 - 2034, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. Porter's Five Force Model
4.5.1. Supplier Power
4.5.2. Buyer Power
4.5.3. Threat Of Substitutes
4.5.4. Threat Of New Entrants
4.5.5. Competitive Rivalry
4.6. PESTEL Analysis
4.6.1. Political Landscape
4.6.2. Economic Landscape
4.6.3. Social Landscape
4.6.4. Technology Landscape
4.6.5. Environmental Landscape
4.6.6. Legal Landscape
5. Neurology Clinical Trials Market: By Phase, 2024-2034, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2025 Versus 2034
5.3. Market Segmentation
5.3.1. Phase I
5.3.2. Phase II
5.3.3. Phase III
5.3.4. Phase IV
6. Neurology Clinical Trials Market: By Study Design, 2024-2034, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2025 Versus 2034
6.3. Market Segmentation
6.3.1. Interventional
6.3.2. Observational
6.3.3. Expanded access
7. Neurology Clinical Trials Market: By Indication, 2024-2034, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2025 Versus 2034
7.3. Market Segmentation
7.3.1. Epilepsy
7.3.2. Parkinson’s Disease
7.3.3. Huntington’s Disease
7.3.4. Stroke
7.3.5. Traumatic brain Injury (TBI)
7.3.6. Amyotrophic Lateral Sclerosis (ALS)
7.3.7. Muscle regeneration
7.3.8. Other Indications
8. North America Neurology Clinical Trials Market, 2024-2034, USD (Million)
8.1. Market Overview
8.2. Neurology Clinical Trials Market: By Phase, 2024-2034, USD (Million)
8.3. Neurology Clinical Trials Market: By Study Design, 2024-2034, USD (Million)
8.4. Neurology Clinical Trials Market: By Indication, 2024-2034, USD (Million)
8.5. Neurology Clinical Trials Market: By Region, 2024-2034, USD (Million)
8.5.1.North America
8.5.1.1. U.S.
8.5.1.1.1. Neurology Clinical Trials Market: By Phase, 2024-2034, USD (Million)
8.5.1.1.2. Neurology Clinical Trials Market: By Study Design, 2024-2034, USD (Million)
8.5.1.1.3. Neurology Clinical Trials Market: By Indication, 2024-2034, USD (Million)
8.5.1.2. Canada
8.5.1.2.1. Neurology Clinical Trials Market: By Phase, 2024-2034, USD (Million)
8.5.1.2.2. Neurology Clinical Trials Market: By Study Design, 2024-2034, USD (Million)
8.5.1.2.3. Neurology Clinical Trials Market: By Indication, 2024-2034, USD (Million)
8.5.1.3. Rest of North America
8.5.1.3.1. Neurology Clinical Trials Market: By Phase, 2024-2034, USD (Million)
8.5.1.3.2. Neurology Clinical Trials Market: By Study Design, 2024-2034, USD (Million)
8.5.1.3.3. Neurology Clinical Trials Market: By Indication, 2024-2034, USD (Million)
9. UK and European Union Neurology Clinical Trials Market, 2024-2034, USD (Million)
9.1. Market Overview
9.2. Neurology Clinical Trials Market: By Phase, 2024-2034, USD (Million)
9.3. Neurology Clinical Trials Market: By Study Design, 2024-2034, USD (Million)
9.4. Neurology Clinical Trials Market: By Indication, 2024-2034, USD (Million)
9.5. Neurology Clinical Trials Market: By Region, 2024-2034, USD (Million)
9.5.1.UK and European Union
9.5.1.1. UK
9.5.1.1.1. Neurology Clinical Trials Market: By Phase, 2024-2034, USD (Million)
9.5.1.1.2. Neurology Clinical Trials Market: By Study Design, 2024-2034, USD (Million)
9.5.1.1.3. Neurology Clinical Trials Market: By Indication, 2024-2034, USD (Million)
9.5.1.2. Germany
9.5.1.2.1. Neurology Clinical Trials Market: By Phase, 2024-2034, USD (Million)
9.5.1.2.2. Neurology Clinical Trials Market: By Study Design, 2024-2034, USD (Million)
9.5.1.2.3. Neurology Clinical Trials Market: By Indication, 2024-2034, USD (Million)
9.5.1.3. Spain
9.5.1.3.1. Neurology Clinical Trials Market: By Phase, 2024-2034, USD (Million)
9.5.1.3.2. Neurology Clinical Trials Market: By Study Design, 2024-2034, USD (Million)
9.5.1.3.3. Neurology Clinical Trials Market: By Indication, 2024-2034, USD (Million)
9.5.1.4. Italy
9.5.1.4.1. Neurology Clinical Trials Market: By Phase, 2024-2034, USD (Million)
9.5.1.4.2. Neurology Clinical Trials Market: By Study Design, 2024-2034, USD (Million)
9.5.1.4.3. Neurology Clinical Trials Market: By Indication, 2024-2034, USD (Million)
9.5.1.5. France
9.5.1.5.1. Neurology Clinical Trials Market: By Phase, 2024-2034, USD (Million)
9.5.1.5.2. Neurology Clinical Trials Market: By Study Design, 2024-2034, USD (Million)
9.5.1.5.3. Neurology Clinical Trials Market: By Indication, 2024-2034, USD (Million)
9.5.1.6. Rest of Europe
9.5.1.6.1. Neurology Clinical Trials Market: By Phase, 2024-2034, USD (Million)
9.5.1.6.2. Neurology Clinical Trials Market: By Study Design, 2024-2034, USD (Million)
9.5.1.6.3. Neurology Clinical Trials Market: By Indication, 2024-2034, USD (Million)
10. Asia Pacific Neurology Clinical Trials Market, 2024-2034, USD (Million)
10.1. Market Overview
10.2. Neurology Clinical Trials Market: By Phase, 2024-2034, USD (Million)
10.3. Neurology Clinical Trials Market: By Study Design, 2024-2034, USD (Million)
10.4. Neurology Clinical Trials Market: By Indication, 2024-2034, USD (Million)
10.5. Neurology Clinical Trials Market: By Region, 2024-2034, USD (Million)
10.5.1.Asia Pacific
10.5.1.1. China
10.5.1.1.1. Neurology Clinical Trials Market: By Phase, 2024-2034, USD (Million)
10.5.1.1.2. Neurology Clinical Trials Market: By Study Design, 2024-2034, USD (Million)
10.5.1.1.3. Neurology Clinical Trials Market: By Indication, 2024-2034, USD (Million)
10.5.1.2. Japan
10.5.1.2.1. Neurology Clinical Trials Market: By Phase, 2024-2034, USD (Million)
10.5.1.2.2. Neurology Clinical Trials Market: By Study Design, 2024-2034, USD (Million)
10.5.1.2.3. Neurology Clinical Trials Market: By Indication, 2024-2034, USD (Million)
10.5.1.3. India
10.5.1.3.1. Neurology Clinical Trials Market: By Phase, 2024-2034, USD (Million)
10.5.1.3.2. Neurology Clinical Trials Market: By Study Design, 2024-2034, USD (Million)
10.5.1.3.3. Neurology Clinical Trials Market: By Indication, 2024-2034, USD (Million)
10.5.1.4. Australia
10.5.1.4.1. Neurology Clinical Trials Market: By Phase, 2024-2034, USD (Million)
10.5.1.4.2. Neurology Clinical Trials Market: By Study Design, 2024-2034, USD (Million)
10.5.1.4.3. Neurology Clinical Trials Market: By Indication, 2024-2034, USD (Million)
10.5.1.5. South Korea
10.5.1.5.1. Neurology Clinical Trials Market: By Phase, 2024-2034, USD (Million)
10.5.1.5.2. Neurology Clinical Trials Market: By Study Design, 2024-2034, USD (Million)
10.5.1.5.3. Neurology Clinical Trials Market: By Indication, 2024-2034, USD (Million)
10.5.1.6. Rest of Asia Pacific
10.5.1.6.1. Neurology Clinical Trials Market: By Phase, 2024-2034, USD (Million)
10.5.1.6.2. Neurology Clinical Trials Market: By Study Design, 2024-2034, USD (Million)
10.5.1.6.3. Neurology Clinical Trials Market: By Indication, 2024-2034, USD (Million)
11. Latin America Neurology Clinical Trials Market, 2024-2034, USD (Million)
11.1. Market Overview
11.2. Neurology Clinical Trials Market: By Phase, 2024-2034, USD (Million)
11.3. Neurology Clinical Trials Market: By Study Design, 2024-2034, USD (Million)
11.4. Neurology Clinical Trials Market: By Indication, 2024-2034, USD (Million)
11.5. Neurology Clinical Trials Market: By Region, 2024-2034, USD (Million)
11.5.1.Latin America
11.5.1.1. Brazil
11.5.1.1.1. Neurology Clinical Trials Market: By Phase, 2024-2034, USD (Million)
11.5.1.1.2. Neurology Clinical Trials Market: By Study Design, 2024-2034, USD (Million)
11.5.1.1.3. Neurology Clinical Trials Market: By Indication, 2024-2034, USD (Million)
11.5.1.2. Mexico
11.5.1.2.1. Neurology Clinical Trials Market: By Phase, 2024-2034, USD (Million)
11.5.1.2.2. Neurology Clinical Trials Market: By Study Design, 2024-2034, USD (Million)
11.5.1.2.3. Neurology Clinical Trials Market: By Indication, 2024-2034, USD (Million)
11.5.1.3. Rest of Latin America
11.5.1.3.1. Neurology Clinical Trials Market: By Phase, 2024-2034, USD (Million)
11.5.1.3.2. Neurology Clinical Trials Market: By Study Design, 2024-2034, USD (Million)
11.5.1.3.3. Neurology Clinical Trials Market: By Indication, 2024-2034, USD (Million)
12. Middle East and Africa Neurology Clinical Trials Market, 2024-2034, USD (Million)
12.1. Market Overview
12.2. Neurology Clinical Trials Market: By Phase, 2024-2034, USD (Million)
12.3. Neurology Clinical Trials Market: By Study Design, 2024-2034, USD (Million)
12.4. Neurology Clinical Trials Market: By Indication, 2024-2034, USD (Million)
12.5. Neurology Clinical Trials Market: By Region, 2024-2034, USD (Million)
12.5.1.Middle East and Africa
12.5.1.1. GCC
12.5.1.1.1. Neurology Clinical Trials Market: By Phase, 2024-2034, USD (Million)
12.5.1.1.2. Neurology Clinical Trials Market: By Study Design, 2024-2034, USD (Million)
12.5.1.1.3. Neurology Clinical Trials Market: By Indication, 2024-2034, USD (Million)
12.5.1.2. Africa
12.5.1.2.1. Neurology Clinical Trials Market: By Phase, 2024-2034, USD (Million)
12.5.1.2.2. Neurology Clinical Trials Market: By Study Design, 2024-2034, USD (Million)
12.5.1.2.3. Neurology Clinical Trials Market: By Indication, 2024-2034, USD (Million)
12.5.1.3. Rest of Middle East and Africa
12.5.1.3.1. Neurology Clinical Trials Market: By Phase, 2024-2034, USD (Million)
12.5.1.3.2. Neurology Clinical Trials Market: By Study Design, 2024-2034, USD (Million)
12.5.1.3.3. Neurology Clinical Trials Market: By Indication, 2024-2034, USD (Million)
13. Company Profile
13.1. Novartis (Company Overview, Financial Performance, Product Portfolio, Strategic Initiatives)
13.2. Covance
13.3. Med pace
13.4. Charles River Laboratories
13.5. Syneous Health
13.6. Icon Plc
13.7. GlaxoSmithKline
13.8. Others
